Janet de Beukelaar - JoVE Visualize

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

Journal of Neurology|March 5, 2026

Symptoms of depression and anxiety are early predictors of multi-domain disability progression in progressive MSRomy A M Klein Kranenbarg, Katelijn M Blok, Yifan van Hasselt, et al.

Frontiers in Immunology|March 14, 2025

The gut-brain-axis one year after treatment with cladribine tablets in patients with relapsing remitting multiple sclerosis: a pilot studyJeske van Pamelen, Carla Rodriguez-Mogeda, Lynn van Olst, et al.

Neurology(R) Neuroimmunology & Neuroinflammation|February 16, 2026

Integrin β1 Demarks Precursors of Brain-Residing Antibody-Secreting Cells in Multiple SclerosisKirsten L Kuiper, Laurens Bogers, Jasper Rip, et al.

European Journal of Immunology|September 3, 2025

Perturbances in Both Circulating B and CD4<sup>+</sup> T Cells Discriminate Multiple Sclerosis from Other Central Nervous System Autoimmune DiseasesLaurens Bogers, Jasper Rip, Suzanne C Franken, et al.

Ebiomedicine|June 6, 2026

Refined single-cell profiling captures a CCR5<sup>high</sup> CD4<sup>+</sup> cytotoxic T-cell precursor in multiple sclerosisFabiënne van Puijfelik, Jasper Rip, Yifan van Hasselt, et al.

JAMA Neurology|December 9, 2024

Discontinuation of First-Line Disease-Modifying Therapy in Patients With Stable Multiple Sclerosis: The DOT-MS Randomized Clinical TrialEline M E Coerver, Wing Hee Fung, Janet de Beukelaar, et al.

Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

Journal of Neurology|March 5, 2026

Symptoms of depression and anxiety are early predictors of multi-domain disability progression in progressive MSRomy A M Klein Kranenbarg, Katelijn M Blok, Yifan van Hasselt, et al.

Frontiers in Immunology|March 14, 2025

The gut-brain-axis one year after treatment with cladribine tablets in patients with relapsing remitting multiple sclerosis: a pilot studyJeske van Pamelen, Carla Rodriguez-Mogeda, Lynn van Olst, et al.

Neurology(R) Neuroimmunology & Neuroinflammation|February 16, 2026

Integrin β1 Demarks Precursors of Brain-Residing Antibody-Secreting Cells in Multiple SclerosisKirsten L Kuiper, Laurens Bogers, Jasper Rip, et al.

European Journal of Immunology|September 3, 2025

Perturbances in Both Circulating B and CD4<sup>+</sup> T Cells Discriminate Multiple Sclerosis from Other Central Nervous System Autoimmune DiseasesLaurens Bogers, Jasper Rip, Suzanne C Franken, et al.

Ebiomedicine|June 6, 2026

Refined single-cell profiling captures a CCR5<sup>high</sup> CD4<sup>+</sup> cytotoxic T-cell precursor in multiple sclerosisFabiënne van Puijfelik, Jasper Rip, Yifan van Hasselt, et al.

JAMA Neurology|December 9, 2024

Discontinuation of First-Line Disease-Modifying Therapy in Patients With Stable Multiple Sclerosis: The DOT-MS Randomized Clinical TrialEline M E Coerver, Wing Hee Fung, Janet de Beukelaar, et al.

Pageof 2